ALTIMMUNE, INC. Long-Term Debt
ALTIMMUNE, INC. (ALT) had Long-Term Debt of $34.74 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-12
- 2026-06-30: Long-term Debt, Excluding Current Maturities $34.74M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $34.51M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $34.29M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $14.45M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-06-30 | $34.74M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $34.51M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $34.29M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $14.45M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $14.33M 10-Q · filed 2025-08-12 | |
| 2023-09-30 | $4.30M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $4.17M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $4.40M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $4.58M 10-Q · filed 2023-11-07 | |
| 2022-09-30 | $4.51M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.53M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.67M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.45M 10-K · filed 2023-02-28 | $1.45M 10-K · filed 2022-03-15 |
| 2021-09-30 | $1.57M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.62M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $1.72M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.83M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $1.93M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.72M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $1.79M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.86M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.79M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $2.21M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $2.32M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $1.85M 10-K · filed 2020-03-27 | |
| 2014-06-30 | $239.74K 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $485.39K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $730.28K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $974.41K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $1.22M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $1.46M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.70M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $1.76M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $1.98M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $2.23M 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |